Click here to get full coverage on LeMaitre Vascular, Inc. $LMAT Shares Sold by JPMorgan Chase & Co. - MarketBeat

LeMaitre Vascular, Inc. $LMAT Shares Sold by JPMorgan Chase & Co.  MarketBeat

LeMaitre Vascular, Inc. $LMAT Shares Sold by JPMorgan Chase & Co. - MarketBeat

Click here to get full coverage on How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance - Yahoo Finance

How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance  Yahoo Finance

How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance - Yahoo Finance

Click here to get full coverage on 2 Profitable Stocks with Exciting Potential and 1 We Turn Down - StockStory

2 Profitable Stocks with Exciting Potential and 1 We Turn Down  StockStory

2 Profitable Stocks with Exciting Potential and 1 We Turn Down - StockStory

Click here to get full coverage on LeMaitre Vascular (LMAT) director gains new stock through awards - Stock Titan

LeMaitre Vascular (LMAT) director gains new stock through awards  Stock Titan

LeMaitre Vascular (LMAT) director gains new stock through awards - Stock Titan

Click here to get full coverage on Lemaitre Vascular SVP Kamke sells $115k in LMAT stock - Investing.com

Lemaitre Vascular SVP Kamke sells $115k in LMAT stock  Investing.com

Lemaitre Vascular SVP Kamke sells $115k in LMAT stock - Investing.com

Click here to get full coverage on LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross - Nasdaq

LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross  Nasdaq

LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross - Nasdaq

Click here to get full coverage on LeMaitre Vascular (LMAT) Is Up 16.4% After Strong Earnings, Dividend Hike And New Buyback Plan – Has The Bull Case Changed? - simplywall.st

LeMaitre Vascular (LMAT) Is Up 16.4% After Strong Earnings, Dividend Hike And New Buyback Plan – Has The Bull Case Changed?  simplywall.st

LeMaitre Vascular (LMAT) Is Up 16.4% After Strong Earnings, Dividend Hike And New Buyback Plan – Has The Bull Case Changed? - simplywall.st

Click here to get full coverage on LeMaitre Vascular Stock: Why Wall Street Sees $109 Mean Target - TIKR.com

LeMaitre Vascular Stock: Why Wall Street Sees $109 Mean Target  TIKR.com

LeMaitre Vascular Stock: Why Wall Street Sees $109 Mean Target - TIKR.com

Click here to get full coverage on LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? - Yahoo Finance

LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed?  Yahoo Finance

LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? - Yahoo Finance

Click here to get full coverage on LeMaitre (NASDAQ: LMAT) director gains PSU-based stock and dividend rights - Stock Titan

LeMaitre (NASDAQ: LMAT) director gains PSU-based stock and dividend rights  Stock Titan

LeMaitre (NASDAQ: LMAT) director gains PSU-based stock and dividend rights - Stock Titan

Click here to get full coverage on LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $6,029,813.30 in Stock - MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $6,029,813.30 in Stock  MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $6,029,813.30 in Stock - MarketBeat

Click here to get full coverage on LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory - Yahoo Finance

LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory  Yahoo Finance

LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on LeMaitre Vascular (LMAT) president reports sale of 8,464 shares - Stock Titan

LeMaitre Vascular (LMAT) president reports sale of 8,464 shares  Stock Titan

LeMaitre Vascular (LMAT) president reports sale of 8,464 shares - Stock Titan

Click here to get full coverage on LeMaitre Vascular (NASDAQ:LMAT) Director Sells $903,955.20 in Stock - MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Director Sells $903,955.20 in Stock  MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Director Sells $903,955.20 in Stock - MarketBeat

Click here to get full coverage on LMAT SEC Filings - Lemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan

LMAT SEC Filings - Lemaitre Vasculr 10-K, 10-Q, 8-K Forms  Stock Titan

LMAT SEC Filings - Lemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts - MarketBeat

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts  MarketBeat

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts - MarketBeat

Click here to get full coverage on LeMaitre Vascular (NASDAQ:LMAT) Insider Sells $115,142.76 in Stock - MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Insider Sells $115,142.76 in Stock  MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Insider Sells $115,142.76 in Stock - MarketBeat

Click here to get full coverage on Five investor conferences spotlight LeMaitre in busy March - Stock Titan

Five investor conferences spotlight LeMaitre in busy March  Stock Titan

Five investor conferences spotlight LeMaitre in busy March - Stock Titan

Click here to get full coverage on LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $16,014,000.00 in Stock - MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $16,014,000.00 in Stock  MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $16,014,000.00 in Stock - MarketBeat

Click here to get full coverage on LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars - Yahoo Finance

LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars  Yahoo Finance

LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars - Yahoo Finance

Click here to get full coverage on LeMaitre (LMAT) Stock Trades Up, Here Is Why - Yahoo Finance

LeMaitre (LMAT) Stock Trades Up, Here Is Why  Yahoo Finance

LeMaitre (LMAT) Stock Trades Up, Here Is Why - Yahoo Finance

Click here to get full coverage on LeMaitre Vascular (LMAT) Shows Promising Technical Prospects Following Significant Golden Cross - Bitget

LeMaitre Vascular (LMAT) Shows Promising Technical Prospects Following Significant Golden Cross  Bitget

LeMaitre Vascular (LMAT) Shows Promising Technical Prospects Following Significant Golden Cross - Bitget

Click here to get full coverage on LeMaitre lifts dividend 25% and okays $100M stock buyback - Stock Titan

LeMaitre lifts dividend 25% and okays $100M stock buyback  Stock Titan

LeMaitre lifts dividend 25% and okays $100M stock buyback - Stock Titan

Click here to get full coverage on LeMaitre (LMAT) To Report Earnings Tomorrow: Here Is What To Expect - Finviz

LeMaitre (LMAT) To Report Earnings Tomorrow: Here Is What To Expect  Finviz

LeMaitre (LMAT) To Report Earnings Tomorrow: Here Is What To Expect - Finviz

Click here to get full coverage on LeMaitre Vascular (LMAT) Margin Expansion Challenges Cautious Growth Narratives After FY 2025 Results - simplywall.st

LeMaitre Vascular (LMAT) Margin Expansion Challenges Cautious Growth Narratives After FY 2025 Results  simplywall.st

LeMaitre Vascular (LMAT) Margin Expansion Challenges Cautious Growth Narratives After FY 2025 Results - simplywall.st

Click here to get full coverage on LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns - Sahm

LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns  Sahm

LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns - Sahm

Click here to get full coverage on LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns - simplywall.st

LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns  simplywall.st

LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns - simplywall.st

Click here to get full coverage on A Look At LeMaitre Vascular (LMAT) Valuation After Recent Share Price Momentum - simplywall.st

A Look At LeMaitre Vascular (LMAT) Valuation After Recent Share Price Momentum  simplywall.st

A Look At LeMaitre Vascular (LMAT) Valuation After Recent Share Price Momentum - simplywall.st

Click here to get full coverage on Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expensive For A Reason? A Look At Its Intrinsic Value - Yahoo Finance

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expensive For A Reason? A Look At Its Intrinsic Value  Yahoo Finance

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expensive For A Reason? A Look At Its Intrinsic Value - Yahoo Finance

Click here to get full coverage on [144] LEMAITRE VASCULAR INC SEC Filing - Stock Titan

[144] LEMAITRE VASCULAR INC SEC Filing  Stock Titan

[144] LEMAITRE VASCULAR INC SEC Filing - Stock Titan

Click here to get full coverage on Is LeMaitre Vascular (LMAT) Pricing Too Rich After Mixed Long Term Returns? - simplywall.st

Is LeMaitre Vascular (LMAT) Pricing Too Rich After Mixed Long Term Returns?  simplywall.st

Is LeMaitre Vascular (LMAT) Pricing Too Rich After Mixed Long Term Returns? - simplywall.st

Click here to get full coverage on LeMaitre Vascular Stock Surges 24% After Q4 Sales Beat. Is the $104 Street Target Still in Play? - TIKR.com

LeMaitre Vascular Stock Surges 24% After Q4 Sales Beat. Is the $104 Street Target Still in Play?  TIKR.com

LeMaitre Vascular Stock Surges 24% After Q4 Sales Beat. Is the $104 Street Target Still in Play? - TIKR.com

Click here to get full coverage on Discipline and Rules-Based Execution in LMAT Response - Stock Traders Daily

Discipline and Rules-Based Execution in LMAT Response  Stock Traders Daily

Discipline and Rules-Based Execution in LMAT Response - Stock Traders Daily

Click here to get full coverage on A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124 - 富途牛牛

A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124  富途牛牛

A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124 - 富途牛牛

Click here to get full coverage on LeMaitre Vascular (NASDAQ:LMAT) Releases FY 2026 Earnings Guidance - MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Releases FY 2026 Earnings Guidance  MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Releases FY 2026 Earnings Guidance - MarketBeat

Click here to get full coverage on LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Citizens Jmp Analyst Says  MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat

Click here to get full coverage on LeMaitre Vascular (LMAT) Gets Price Target Boost from Barrington Research | LMAT Stock News - GuruFocus

LeMaitre Vascular (LMAT) Gets Price Target Boost from Barrington Research | LMAT Stock News  GuruFocus

LeMaitre Vascular (LMAT) Gets Price Target Boost from Barrington Research | LMAT Stock News - GuruFocus

Click here to get full coverage on LMAT Price Target Raised by Wells Fargo | LMAT Stock News - GuruFocus

LMAT Price Target Raised by Wells Fargo | LMAT Stock News  GuruFocus

LMAT Price Target Raised by Wells Fargo | LMAT Stock News - GuruFocus

Click here to get full coverage on LeMaitre Vascular (LMAT) Reports Strong Q4 2025 Performance and Positive 2026 Outlook - GuruFocus

LeMaitre Vascular (LMAT) Reports Strong Q4 2025 Performance and Positive 2026 Outlook  GuruFocus

LeMaitre Vascular (LMAT) Reports Strong Q4 2025 Performance and Positive 2026 Outlook - GuruFocus

Click here to get full coverage on LeMaitre Vascular: The Compounder Keeps Compounding (NYSE:MDT) - Seeking Alpha

LeMaitre Vascular: The Compounder Keeps Compounding (NYSE:MDT)  Seeking Alpha

LeMaitre Vascular: The Compounder Keeps Compounding (NYSE:MDT) - Seeking Alpha

Click here to get full coverage on LeMaitre Vascular (NASDAQ:LMAT) Rating Increased to Buy at Wall Street Zen - MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Rating Increased to Buy at Wall Street Zen  MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Rating Increased to Buy at Wall Street Zen - MarketBeat

Click here to get full coverage on LMAT Analyst Rating: Roth Capital Reiterates and Raises Price Ta - GuruFocus

LMAT Analyst Rating: Roth Capital Reiterates and Raises Price Ta  GuruFocus

LMAT Analyst Rating: Roth Capital Reiterates and Raises Price Ta - GuruFocus

Click here to get full coverage on LMAT: Citizens Raises Price Target to $118, Maintains Market Out - GuruFocus

LMAT: Citizens Raises Price Target to $118, Maintains Market Out  GuruFocus

LMAT: Citizens Raises Price Target to $118, Maintains Market Out - GuruFocus

Click here to get full coverage on LeMaitre Vascular (LMAT) Expected to Announce Earnings on Wednesday - MarketBeat

LeMaitre Vascular (LMAT) Expected to Announce Earnings on Wednesday  MarketBeat

LeMaitre Vascular (LMAT) Expected to Announce Earnings on Wednesday - MarketBeat

Click here to get full coverage on LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 13.45% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 13.45% Upside Potential in the Healthcare Sector  DirectorsTalk Interviews

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 13.45% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews

Click here to get full coverage on Behavioral Patterns of LMAT and Institutional Flows - Stock Traders Daily

Behavioral Patterns of LMAT and Institutional Flows  Stock Traders Daily

Behavioral Patterns of LMAT and Institutional Flows - Stock Traders Daily

Click here to get full coverage on 3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT) - Yahoo Finance

3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT)  Yahoo Finance

3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT) - Yahoo Finance

Click here to get full coverage on LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year High After Strong Earnings - MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year High After Strong Earnings  MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year High After Strong Earnings - MarketBeat

Click here to get full coverage on LeMaitre Vascular (NASDAQ:LMAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS  MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Click here to get full coverage on LeMaitre (LMAT) To Report Earnings Tomorrow: Here Is What To Expect - FinancialContent

LeMaitre (LMAT) To Report Earnings Tomorrow: Here Is What To Expect  FinancialContent

LeMaitre (LMAT) To Report Earnings Tomorrow: Here Is What To Expect - FinancialContent

Click here to get full coverage on LeMaitre Vascular (NASDAQ:LMAT) Updates Q1 2026 Earnings Guidance - MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Updates Q1 2026 Earnings Guidance  MarketBeat

LeMaitre Vascular (NASDAQ:LMAT) Updates Q1 2026 Earnings Guidance - MarketBeat

Click here to get full coverage on (LMAT) LeMaitre Vascular, Inc. Expects Q1 Revenue Range $65.6M - $67.6M - marketscreener.com

(LMAT) LeMaitre Vascular, Inc. Expects Q1 Revenue Range $65.6M - $67.6M  marketscreener.com

(LMAT) LeMaitre Vascular, Inc. Expects Q1 Revenue Range $65.6M - $67.6M - marketscreener.com

Click here to get full coverage on LeMaitre (LMAT) Stock Trades Up, Here Is Why - The Chronicle-Journal

LeMaitre (LMAT) Stock Trades Up, Here Is Why  The Chronicle-Journal

LeMaitre (LMAT) Stock Trades Up, Here Is Why - The Chronicle-Journal

Click here to get full coverage on LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2025 Earnings Call Transcript - Insider Monkey

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2025 Earnings Call Transcript  Insider Monkey

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Barrington Research Reaffirms "Outperform" Rating for LeMaitre Vascular (NASDAQ:LMAT) - MarketBeat

Barrington Research Reaffirms "Outperform" Rating for LeMaitre Vascular (NASDAQ:LMAT)  MarketBeat

Barrington Research Reaffirms "Outperform" Rating for LeMaitre Vascular (NASDAQ:LMAT) - MarketBeat

Click here to get full coverage on LeMaitre: Q4 Earnings Snapshot - theheraldreview.com

LeMaitre: Q4 Earnings Snapshot  theheraldreview.com

LeMaitre: Q4 Earnings Snapshot - theheraldreview.com

Click here to get full coverage on Final Trade: LMAT, REGN, BA, TJX - CNBC

Final Trade: LMAT, REGN, BA, TJX - CNBC

Click here to get full coverage on Here's Why LeMaitre Vascular (NASDAQ:LMAT) Has Caught The Eye Of Investors - simplywall.st

Here's Why LeMaitre Vascular (NASDAQ:LMAT) Has Caught The Eye Of Investors  simplywall.st

Here's Why LeMaitre Vascular (NASDAQ:LMAT) Has Caught The Eye Of Investors - simplywall.st

Click here to get full coverage on LeMaitre Vascular, Inc. $LMAT Shares Sold by Envestnet Asset Management Inc. - MarketBeat

LeMaitre Vascular, Inc. $LMAT Shares Sold by Envestnet Asset Management Inc.  MarketBeat

LeMaitre Vascular, Inc. $LMAT Shares Sold by Envestnet Asset Management Inc. - MarketBeat

Click here to get full coverage on LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars - The Chronicle-Journal

LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars  The Chronicle-Journal

LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars - The Chronicle-Journal

Click here to get full coverage on Earnings Flash (LMAT) LeMaitre Vascular, Inc. Reports Q4 Revenue $64.5M, vs. FactSet Est of $62.8M - marketscreener.com

Earnings Flash (LMAT) LeMaitre Vascular, Inc. Reports Q4 Revenue $64.5M, vs. FactSet Est of $62.8M  marketscreener.com

Earnings Flash (LMAT) LeMaitre Vascular, Inc. Reports Q4 Revenue $64.5M, vs. FactSet Est of $62.8M - marketscreener.com

Click here to get full coverage on LeMaitre Vascular, Inc. (LMAT) Investor Outlook: Exploring an 18% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews

LeMaitre Vascular, Inc. (LMAT) Investor Outlook: Exploring an 18% Potential Upside in the Medical Devices Sector  DirectorsTalk Interviews

LeMaitre Vascular, Inc. (LMAT) Investor Outlook: Exploring an 18% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews

Click here to get full coverage on Exploring LeMaitre Vascular's Earnings Expectations - Benzinga

Exploring LeMaitre Vascular's Earnings Expectations  Benzinga

Exploring LeMaitre Vascular's Earnings Expectations - Benzinga

Click here to get full coverage on LeMaitre (LMAT) Stock Trades Up, Here Is Why - FinancialContent

LeMaitre (LMAT) Stock Trades Up, Here Is Why  FinancialContent

LeMaitre (LMAT) Stock Trades Up, Here Is Why - FinancialContent

Click here to get full coverage on 1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Find Risky - StockStory

1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Find Risky  StockStory

1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Find Risky - StockStory

Click here to get full coverage on Here is Why Growth Investors Should Buy LeMaitre (LMAT) Now - Nasdaq

Here is Why Growth Investors Should Buy LeMaitre (LMAT) Now  Nasdaq

Here is Why Growth Investors Should Buy LeMaitre (LMAT) Now - Nasdaq

Click here to get full coverage on Ranger Investment Management L.P. Lowers Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat

Ranger Investment Management L.P. Lowers Stock Position in LeMaitre Vascular, Inc. $LMAT  MarketBeat

Ranger Investment Management L.P. Lowers Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat

Click here to get full coverage on LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Potential 19.79% Upside and Robust Growth in the Healthcare Sector - DirectorsTalk Interviews

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Potential 19.79% Upside and Robust Growth in the Healthcare Sector  DirectorsTalk Interviews

LMAT

Price Chart

Key Statistics

Technicals

About LMAT

Latest News

LeMaitre Vascular, Inc. $LMAT Shares Sold by JPMorgan Chase & Co. - MarketBeat

How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance - Yahoo Finance

2 Profitable Stocks with Exciting Potential and 1 We Turn Down - StockStory

Advanced Charts

Top Gainers

Top Losers